Patents by Inventor Alberto Bartorelli

Alberto Bartorelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • UK 114 SALMON PROTEINS FOR USE IN THE TREATMENT, DIAGNOSIS AND PREVENTION OF MALIGNANT TUMOURS
    Publication number: 20230000946
    Abstract: Disclosed are UK 114 salmon proteins for use in the treatment, diagnosis and prevention of malignant tumours.
    Type: Application
    Filed: November 23, 2020
    Publication date: January 5, 2023
    Inventor: Alberto Bartorelli Cusani
  • Recombinant protein UK 114 in stable polymer form for use in the treatment, diagnosis and prevention of malignant solid and systemic tumours
    Patent number: 11352398
    Abstract: Disclosed is a novel recombinant protein UK 114 in stable polymer form for use in the treatment, diagnosis and prevention of malignant solid and systemic tumours.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: June 7, 2022
    Inventor: Alberto Bartorelli Cusani
  • NOVEL RECOMBINANT PROTEIN UK 114 IN STABLE POLYMER FORM FOR USE IN THE TREATMENT, DIAGNOSIS AND PREVENTION OF MALIGNANT SOLID AND SYSTEMIC TUMOURS
    Publication number: 20200017559
    Abstract: Disclosed is a novel recombinant protein UK 114 in stable polymer form for use in the treatment, diagnosis and prevention of malignant solid and systemic tumours.
    Type: Application
    Filed: December 14, 2017
    Publication date: January 16, 2020
    Inventor: Alberto BARTORELLI CUSANI
  • Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors
    Patent number: 10098927
    Abstract: The present invention refers to a combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, immunoglobulins and chemotactic factors. The invention also relates to a process for the preparation of said combination from serum, placenta or colostrum and to composition containing said combination for use in the treatment of conditions requiring tissue repair and regeneration and for the substitution of stem cell therapies.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: October 16, 2018
    Assignee: INNOMED S.A.
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • COMBINATION OF GROWTH FACTORS, CYTOKINES, ANTIBACTERIAL/ANTIVIRAL FACTORS, STEM CELL STIMULATING FACTORS, COMPLEMENT PROTEINS C3A/C4A, IMMUNOGLOBULINS AND CHEMOTACTIC FACTORS
    Publication number: 20170087213
    Abstract: The present invention refers to a combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, immunoglobulins and chemotactic factors. The invention also relates to a process for the preparation of said combination from serum, placenta or colostrum and to composition containing said combination for use in the treatment of conditions requiring tissue repair and regeneration and for the substitution of stem cell therapies.
    Type: Application
    Filed: December 13, 2016
    Publication date: March 30, 2017
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, immunoglobulins and chemotactic factors
    Patent number: 9555084
    Abstract: The present invention refers to a combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, immunoglobulins and chemotactic factors. The invention also relates to a process for the preparation of said combination from serum, placenta or colostrum and to composition containing said combination for use in the treatment of conditions requiring tissue repair and regeneration and for the substitution of stem cell therapies.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: January 31, 2017
    Assignee: INNOMED S.A.
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors
    Patent number: 9492512
    Abstract: The present invention refers to a combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, and chemotactic factors. The invention also relates to a process for the preparation of said combination from serum, placenta or colostrum and to composition containing said combination for use in the treatment of conditions requiring tissue repair and regeneration and for the substitution of stem cell therapies.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: November 15, 2016
    Assignee: INNOMED S.A.
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • Multipurpose gel for vaginal dryness with direct and delayed effect
    Patent number: 9248151
    Abstract: The present invention relates to topical vaginal compositions in gel form containing immune mediators, growth factors, chemotactic factors and antibacterial/antiviral factors extracted from bovine colostrum, and optionally other ingredients with complementary activity.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: February 2, 2016
    Assignee: ZAMBON S.P.A.
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • COMBINATION OF GROWTH FACTORS, CYTOKINES, ANTIBACTERIAL/ANTIVIRAL FACTORS, STEM CELL STIMULATING FACTORS, COMPLEMENT PROTEINS C3A/C4A, AND CHEMOTACTIC FACTORS
    Publication number: 20150010497
    Abstract: The present invention refers to a combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, and chemotactic factors. The invention also relates to a process for the preparation of said combination from serum, placenta or colostrum and to composition containing said combination for use in the treatment of conditions requiring tissue repair and regeneration and for the substitution of stem cell therapies.
    Type: Application
    Filed: December 27, 2012
    Publication date: January 8, 2015
    Applicant: BIONEST LTD.
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • COMBINATION OF GROWTH FACTORS, CYTOKINES, ANTIBACTERIAL/ANTIVIRAL FACTORS, STEM CELL STIMULATING FACTORS, COMPLEMENT PROTEINS C3A/C4A, IMMUNOGLOBULINS AND CHEMOTACTIC FACTORS
    Publication number: 20140369957
    Abstract: The present invention refers to a combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, immunoglobulins and chemotactic factors. The invention also relates to a process for the preparation of said combination from serum, placenta or colostrum and to composition containing said combination for use in the treatment of conditions requiring tissue repair and regeneration and for the substitution of stem cell therapies.
    Type: Application
    Filed: December 27, 2012
    Publication date: December 18, 2014
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • MULTIPURPOSE GEL FOR VAGINAL DRYNESS WITH DIRECT AND DELAYED EFFECT
    Publication number: 20140322329
    Abstract: The present invention relates to topical vaginal compositions in gel form containing immune mediators, growth factors, chemotactic factors and antibacterial/antiviral factors extracted from bovine colostrum, and optionally other ingredients with complementary activity.
    Type: Application
    Filed: December 2, 2011
    Publication date: October 30, 2014
    Applicant: ZAMBON S.P.A.
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • Calcium salts with cytotoxic activity
    Patent number: 7423063
    Abstract: Calcium salts, in particular calcium trifluoroacetate, are added to medicaments to provide cytotoxic and antitumoral activity. The medicaments can be administered to cancer patients as part of a method of treating a cancer patient. The medicaments can also be applied to a tumor to treat the tumor. The medicaments may be administered or applied orally or parenterally.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: September 9, 2008
    Assignee: Eureon AG
    Inventor: Alberto Bartorelli
  • Calcium salts with cytotoxic activity
    Publication number: 20040180956
    Abstract: The present invention relates to the use of calcium salts, in particular calcium trifluoroacetate, to prepare medicaments with cytotoxic and antitumoral activity.
    Type: Application
    Filed: May 7, 2004
    Publication date: September 16, 2004
    Inventor: Alberto Bartorelli
  • Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock
    Publication number: 20040180835
    Abstract: Use of the protein UK114 or of fragments thereof for the treatment and prevention of the endotoxic shock.
    Type: Application
    Filed: April 12, 2004
    Publication date: September 16, 2004
    Inventors: Alberto Bartorelli, Pierferdinando Nicoletti, Alberto Panerai
  • Use of the protein uk114 for the treatment and the prevention of chronic active hepatitis
    Publication number: 20040146523
    Abstract: The use of the protein UK114, also known as MSP 14, for the preparation of medicaments for the treatment or the prophylaxis of chronic active hepatitis.
    Type: Application
    Filed: March 15, 2004
    Publication date: July 29, 2004
    Inventors: Alberto Bartorelli, Pierferdinando Nicoletti, Alberto Panerai
  • Pharmaceutical compositions containing proteins
    Publication number: 20030152565
    Abstract: A pharmaceutical composition with anti-tumor effect, consisting essentially of purified protein-disulfide isomerase in admixture with a pharmaceutically acceptable excipient. The isomerase is selected from the group consisting of ERp72, ERp60, P5, and calsequestrin. A method of combating tumors in humans, comprises administering to a human in need thereof a pharmaceutically effective amount of purified protein-disulfide isomerase in admixture with a pharmaceutically acceptable excipient, the effective amount being 1-10 mg.
    Type: Application
    Filed: February 24, 2003
    Publication date: August 14, 2003
    Applicant: PHARMAPRODUCTS UK LIMITED
    Inventor: Alberto Bartorelli
  • Use of proteins as agents against autoimmune diseases
    Publication number: 20030108558
    Abstract: The use of proteins extracted with perchloric acid from animal organs, for the preparation of medicaments active against autoimmune diseases, in particular with activity against atheroscelerosis, arthritis, multiple sclerosis, and diabetes.
    Type: Application
    Filed: September 3, 2002
    Publication date: June 12, 2003
    Applicant: ZETESIS S.p.A
    Inventors: Alberto Panerai, Alberto Bartorelli
  • Recombinant protein and its use in therapy and diagnostics
    Publication number: 20020193308
    Abstract: A new protein obtained through recombinant DNA techniques which can be used in diagnostics and in therapy, in particular for treating tumors, a cDNA molecule encoding such a protein, a process for preparing it, and expression vectors and host cells which may be used in such a process.
    Type: Application
    Filed: May 17, 2002
    Publication date: December 19, 2002
    Applicant: ZETESIS S.P.A.
    Inventors: Vytautas Naktinis, Daniela Concas Benevelli, Bruno Berra, Irma Colombo, Severino Ronchi, Alberto Bartorelli, Viadas Algirdus Bumelis
  • Use of proteins as anti-diabetes agents
    Patent number: 6468536
    Abstract: The use of proteins extracted with perchloric acid from animal organs for the preparation of medicaments active against autoimmune diseases, in particular with activity against atherosclerosis, arthritis, multiple sclerosis, and diabetes.
    Type: Grant
    Filed: April 6, 1999
    Date of Patent: October 22, 2002
    Assignee: Zetesis S.p.A.
    Inventors: Alberto Panerai, Alberto Bartorelli
  • RECOMBINANT PROTEIN AND ITS USE IN THERAPY AND DIAGNOSTICS
    Publication number: 20010014471
    Abstract: A new protein obtained through recombinant DNA techniques which can be used in diagnostics and in therapy, in particular for treating tumors, a cDNA molecule encoding such a protein, a process for preparing it and the expression vectors and host cells used in such a process.
    Type: Application
    Filed: April 15, 1999
    Publication date: August 16, 2001
    Inventors: VYTAUTAS NAKTINIS, DANIELA CONCAS BENEVELLI, BRUNO BERRA, IRMA COLOMBO, SEVERINO RONCHI, ALBERTO BARTORELLI, VIADAS ALGIRDUS BUMELIS